Medicine & Life Sciences
Inflammatory Bowel Diseases
100%
Crohn Disease
92%
Tumor Necrosis Factor Inhibitors
52%
United States Food and Drug Administration
29%
Magnetic Resonance Spectroscopy
29%
Ulcerative Colitis
29%
vedolizumab
26%
Tumor Necrosis Factor-alpha
25%
Ustekinumab
23%
Ischemic Colitis
20%
Tomography
18%
Therapeutics
15%
Non-alcoholic Fatty Liver Disease
14%
Mesalamine
14%
tofacitinib
13%
SARS Virus
13%
Immunologic Factors
12%
Vaccination
12%
Restorative Proctocolectomy
12%
Chronic Disease
11%
Bariatric Surgery
11%
Pouchitis
11%
Vaccines
11%
Inflammation
11%
Endoscopy
10%
Radiologists
9%
Safety
9%
sodium phosphate
9%
Infliximab
9%
Severe Acute Respiratory Syndrome
8%
Coronavirus
8%
T-Cell Lymphoma
7%
Celiac Disease
7%
Systematic Reviews
7%
Rheumatoid Arthritis
7%
Fistula
7%
Pathologic Constriction
7%
Anti-Idiotypic Antibodies
7%
Clinical Trials
7%
Lawyers
7%
Confidence Intervals
7%
Biological Therapy
6%
Protons
6%
Gastroenterologists
6%
Messenger RNA
6%
Inpatients
6%
Antibodies
6%
Biological Products
6%
Pharmaceutical Preparations
6%
Inflammatory Bowel Disease 6
6%